Opportunistic Community Screening of Chronic Chagas Disease Using a Rapid Diagnosis Test in Pharmacies in Barcelona (Catalonia, Spain): Study Protocol and Pilot Phase Results

Objectives: This study aimed to report the protocol and results from the pilot phase of an opportunistic CP-based CD screening program in Barcelona, Spain. Methods: Three strategies according to recruitment approach were designed: passive, active and active-community. The study process consisted of signing the informed consent form, recording the patient’s data in a web-based database system, and performing the rapid test and blood collection on dry paper. Results: Nineteen pharmacies participated and 64 patients were included during the pilot phase of the study. The rapid diagnostic test (RDT) was positive in 2/64 (3.13%) cases. Of the 49 DBS samples that arrived at the laboratory, 22 (45%) were collected incorrectly. After quantitative and qualitative assessment of the program, the dry paper sample and passive strategy were ruled out. Conclusion: DBS sampling and the passive strategy are not suitable for CD screening in community pharmacies. There is a need to expand the number of participating pharmacies and individuals to determine whether conducting a RDT in community pharmacies is an effective screening method to increase access to CD diagnosis in a non-endemic area.

[1]  A. Requena-Méndez,et al.  Estimating chagas disease prevalence and number of underdiagnosed, and undertreated individuals in Spain. , 2022, Travel medicine and infectious disease.

[2]  T. Pumarola,et al.  Analytical Evaluation of Dried Blood Spot and Rapid Diagnostic Test as a New Strategy for Serological Community Screening for Chronic Chagas Disease , 2021, Frontiers in Cellular and Infection Microbiology.

[3]  V. Moreno,et al.  Positive impact of a faecal-based screening programme on colorectal cancer mortality risk , 2021, PloS one.

[4]  J. Casabona,et al.  The contribution of HIV point-of-care tests in early HIV diagnosis: community-based HIV testing monitoring in Catalonia, 1995 to 2018 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  S. Robinson,et al.  Little to Give, Much to Gain—What Can You Do With a Dried Blood Spot? , 2020, Current Environmental Health Reports.

[6]  E. Sulleiro,et al.  Comparative evaluation of community interventions for the immigrant population of Latin American origin at risk for Chagas disease in the city of Barcelona , 2020, PloS one.

[7]  Laura Fontana Sierra.  Pandemia y rearticulación de las relaciones sociales , 2020 .

[8]  C. Morillo,et al.  WHF IASC Roadmap on Chagas Disease , 2020, Global heart.

[9]  A. Benito,et al.  The role of the first level of health care in the approach to Chagas disease in a non-endemic country , 2019, PLoS neglected tropical diseases.

[10]  E. Sulleiro,et al.  A Community-Based Intervention for the Detection of Chagas Disease in Barcelona, Spain , 2019, Journal of Community Health.

[11]  F. Gobbi,et al.  Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis , 2019, PLoS neglected tropical diseases.

[12]  I. Molina,et al.  Chagas disease , 2018, The Lancet.

[13]  D. Moore,et al.  Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis , 2019 .

[14]  J. Stanaway,et al.  The burden of Chagas disease: estimates and challenges. , 2015, Global heart.

[15]  Ties Hoomans,et al.  Economic evaluation of implementation strategies in health care , 2014, Implementation Science.

[16]  R. Gilman,et al.  Field Evaluation of the InBios Chagas Detect Plus Rapid Test in Serum and Whole-Blood Specimens in Bolivia , 2014, Clinical and Vaccine Immunology.

[17]  Javier Nieto,et al.  Comparative Evaluation of 11 Commercialized Rapid Diagnostic Tests for Detecting Trypanosoma cruzi Antibodies in Serum Banks in Areas of Endemicity and Nonendemicity , 2014, Journal of Clinical Microbiology.

[18]  M. Klepser,et al.  Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. , 2014, Journal of the American Pharmacists Association : JAPhA.

[19]  T. Porteous,et al.  Screening for major diseases in community pharmacies: a systematic review , 2013, The International journal of pharmacy practice.

[20]  P. Hotez,et al.  Global economic burden of Chagas disease: a computational simulation model. , 2013, The Lancet. Infectious diseases.

[21]  R. López-Vélez,et al.  Chagas Disease in Non-Endemic Countries: Epidemiology, Clinical Presentation and Treatment , 2012, Current Infectious Disease Reports.

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.